Shanxi C&Y Pharmaceutical Co Ltd, established in June 2010, mainly focuses on research, development and sale of generic drugs, psychoactive drugs, APIs and fine chemicals. The formulations of its products include powder injection, tablet, hard capsule, granule, powder and suppository.In August 2013, C&Y Pharmaceutical intended to use part of its raised funds to build an R&D Center in Shanghai Pudong District Zhangjiang High-Tech Park, Shanghai. The R&D center would focus on development of drugs for cancer, diabetes, geriatrics and chronic disease treatments and new chemical drug preparations, natural drugs, and TCM compound preparations with self-owned intellectual property right. The total available project raised fund was RMB 27.8925 million (US $ 4.52264 million).In November 2019, Shanxi C&Y planned to invest RMB 156 million to acquire 42% stock right of Nantong Hengjia Pharmaceutical.In August 2013, Shanxi C&Y Pharmaceutical planned to acquire 80% stock right of Hangzhou Pollent Ph